Hims & Hers

New hires
By  Laura Lovett 02:52 pm January 25, 2022
Dr. Mandy Cohen, former Secretary of North Carolina's Department of Health and Human services, is joining health tech company Aledade. She will now serve as the executive vice president and CEO of Aledade's new health service unit. Aledade focuses on teaming up with providers to build tech-enabled accountable care organizations.  Cohen has worked in the public sector for more than 15 years. Her...
Hers female hair lloss
By  Laura Lovett 02:46 pm January 14, 2022
Direct-to-consumer virtual healthcare company Hims & Hers has a long history of treating hair loss in men, but today the company is rolling out two new products focused on the issue in women.  Customers experiencing hair loss will now be able to access a topical Finasteride and Minoxidil spray, as well as oral spironolactone, a pill that can decrease androgen levels. Users can take a hair...
Interview
By  Laura Lovett 11:15 am December 15, 2021
Direct-to-consumer virtual health company Hims & Hers Health announced its plans to grow its Medical Advisory Board from five members to 15 members. The new members come from an array of medical specialties including urology, mental health and infectious disease.  This news comes roughly a year after the company went public through a SPAC merger. Since listing on the New York Stock Exchange,...
A person standing at desk looking at a smartphone
By  Emily Olsen 12:53 pm November 30, 2021
Direct-to-consumer virtual care company Hims & Hers is partnering with Uber to deliver personal care items like skincare, hair products, sleep aids and condoms to customers via the Uber Eats app. The service is available now in Los Angeles, San Francisco, Sacramento, Miami, Houston, Austin, Dallas, San Antonio, Philadelphia, Seattle, Atlanta and Phoenix, although the companies plan to expand...
Hims & Hers UTI dietary supplement powder packet
By  Mallory Hackett 11:40 am September 16, 2021
Direct-to-consumer virtual care company Hims & Hers is once again expanding its product line, this time with the launch of a dietary supplement powder to support urinary tract health. Hims & Hers is selling the powder in packs of 10 cranberry-raspberry flavored single-serve packets. The ingredients include D-mannose, a sugar found in cranberry juice; electrolytes like calcium, magnesium...
A telehealth visit via smartphone
By  Dr. Patrick Carroll 11:27 am August 20, 2021
By now everyone knows that virtual care usage exploded over the last year, forging a new competitive era of telehealth. While more choice and greater access are generally good things for consumers in any industry (and this is also true for healthcare where patients, our “consumers,” have historically had neither) the growing virtual care market also has the potential to lead to a more fragmented ...
M&A
By  Laura Lovett 11:39 am June 24, 2021
Direct-to-consumer virtual care company Hims & Hers Health is looking to expand its skincare services, and has announced plans to buy teledermatology platform Apostrophe for an undisclosed sum. This comes just weeks after the company revealed that it was acquiring British telehealth company Honest Health with an eye to continue its U.K. expansion and enter the E.U. market. Apostrophe...
M&A
By  Laura Lovett 01:30 pm June 14, 2021
Direct-to-consumer telehealth company Hims & Hers is looking to go global with its new acquisition of British personalized health company Honest Health for an undisclosed sum. Founded in 2018, Honest Health specializes in providing hair-loss-related products to customers and currently has an exclusive relationship set up with a U.K. compounding pharmacy and fulfillment center. Like Hims...
Stethoscope, money and a calculator.
By  Mallory Hackett 02:39 pm May 17, 2021
Consumer telehealth and wellness brand Hims & Hers came out on top of its projections for the first quarter of 2021, according to its financial results report released today. In its report from Q4 2020, Hims & Hers estimated its revenue to total between $48 million and $50 million, while adjusted EBITDA was expected to land within -$9.5 million and -$11.5 million. “Building on our...
By  Dave Muoio 03:17 pm March 22, 2021
Shares of consumer-friendly telehealth and wellness company Hims & Hers took a hit late last week when the company pulled back the curtain on its first quarterly earnings since going public through a special purpose acquisition company (SPAC) merger. While the company posted 2020 revenue that beat market expectations, its roughly $16 trading price immediately dipped from about $16 to the $14...